Oncological risks of MTHFR, BRCA1 AND BRCA2 gene mutations in patients with chronic endometritis
article
OA: diamond
CC0
Abstract
Aim. To assess the oncological risks for the MTHFR, BRCA1 and BRCA2 gene mutation in patients with chronic endometritis.
Materials and methods. Eighty six patients were examined: 33 practically healthy women and 53 patients with chronic endometritis. A part of the DNA of MTHFR (C677T, A1298C), BRCA1 (3361C > T), BRCA2 (Ser455Ser) genes was used as primers, ultrasound investigation of the mammary glands was implemented.
Results. Among patients with chronic endometritis, there was detected a high rate of benign mammary gland dysplasia, chronic pathology of gastrointestinal tract organs.
Conclusions. Patients with chronic endometritis have significant oncological risks, minor MTHFR and BRCA1 gene alleles were revealed in them more often than major ones, that, against the background of raised oncological pathology, acquires special significance.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (14)
- Clinical Lecture on the Treatment of Chronic Endometritis via openalex
- Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease? via openalex
- W1978953221 via openalex
- W1983174663 via openalex
- W2016853666 via openalex
- W2033763269 via openalex
- W2064153040 via openalex
- W2158621858 via openalex
- W2163195447 via openalex
- W2295345493 via openalex
- W2537634783 via openalex
- W1861209549 via openalex
- W2891019025 via openalex
- W1973621007 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK